Quarterly report pursuant to Section 13 or 15(d)

Stock Compensation Plan

v3.24.2.u1
Stock Compensation Plan
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Compensation Plan

9. Stock Compensation Plan

 

On September 29, 2023, the Board of Directors approved an amendment to the 2021 Equity Incentive Plan (the “Incentive Plan”) to increase the authorized shares available under the Incentive Plan by 1,000,000. The amendment was approved by the Shareholders on December 14, 2023.

 

The Incentive Plan, as amended, provides aggregate number of shares of Common Stock that may be issued under the 2021 Plan will not exceed the sum of (i) 1,166,167 new shares, plus (ii) any shares remaining available for the grant of new awards under the 2012 Plan as of immediately prior to the effective date of the 2021 Equity Incentive Plan; plus, (iii) certain shares subject to outstanding awards granted under the 2012 Plan that may become available for issuance under the 2021 Equity Incentive Plan, as such shares become available from time to time.

 

Options are granted at the fair market value of the Company’s stock on the date of the grant which determines the exercise price after the completion of the vesting period. Options can vest either immediately or over a period of up to three years from their respective grant dates and expire 10 years from the date of grant. As of June 30, 2024 and December 31, 2023, the Company did not award any stock appreciation rights under the Incentive Plan.

 

A summary of stock option activity for the six months ended June 30, 2024 is as follows:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted Average

Remaining Contractual

Term (In Years)

   

Aggregate

Intrinsic Value(1)

 
Outstanding at December 31, 2023     244,733     $ 20.17       7.96     $  
Granted                     $  
Expired     (17,146 )     28.44           $  
Forfeited     (4,667 )     11.52             $  
Outstanding at June 30, 2024     222,920     $ 19.72       8.29     $  
                                 
Exercisable at June 30, 2024     186,370     $ 22.55       8.07     $  

 

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2023 and June 30, 2024; respectively.

 

As of June 30, 2024, an aggregate of 222,920 shares of common stock are covered by outstanding option awards and 1,042,812 shares of common stock are available for future awards under the Incentive Plan.

 

Total compensation cost related to stock options was approximately $58,220 and $63,628 for the three months ended June 30, 2024 and 2023, respectively. Total compensation cost related to stock options was approximately $127,564 and $143,594 for the six months ended June 30, 2024 and 2023, respectively. As of June 30, 2024, there was approximately $160,927 of unrecognized compensation costs related to stock options, which is expected to be recognized over a weighted average period of less than one year.

 

 

Restricted stock grant activity during the six months ended June 30, 2024 was as follows:

 

 Schedule of Restricted Stock Activity

    Number of Shares    

Weighted

Average

Grant Date

Fair Value

 
Non-vested restricted stock at December 31, 2023     6,000     $ 3.37  
Vested     (6,000 )     3.37  
Non-vested restricted stock at June 30, 2024         $  

 

Total compensation cost related to restricted stock awards was approximately $5,000 for the six months ended June 30, 2024. There was no compensation cost related to restricted stock awards for the three months ended June 30, 2024.